Astellas Pharma Inc.

OTC: ALPMY · Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT

Astellas Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash & Equivalents
188.37B 179.87B 292.99B 302.93B 335.69B 253.98B 333.99B 561.49B 376.84B 381.82B 361.07B 313.01B 315.99B 350.21B 318.3B 301.92B 326.13B 306.51B 286.73B 239.93B
Short-Term Investments
29.94B n/a 36.26B n/a 28.78B 31.46B 29.66B 41.33B 19.78B 31.48B 31.95B 23.75B 21.3B 17.88B 9.99B 4.08B 5.56B 19.97B 7.7B 4.59B
Long-Term Investments
18.99B 19.15B 169.67B 19.48B 144.42B 138.03B 140.33B 133.45B 134.75B 127.51B 128.96B 133.41B 131.68B 134.67B 128.05B 132.4B 136.89B 161.9B 135.51B 131.19B
Other Long-Term Assets
153.25B 251.71B 1M 218.86B 18.6B 8.59B 8.72B 9.52B 10.28B 10.91B 11.82B 12.78B 9.53B 10.07B 9.27B 9.65B -274.1B 51.51B 55.23B 55.49B
Receivables
632.52B 644.63B 558.27B 587.67B 534.99B 495.96B 487.89B 462.5B 427.96B 451.27B 452.49B 438.41B 382.46B 373.92B 357.8B 364.23B 343.18B 345.61B 332.73B 360.72B
Inventory
297.26B 287.34B 260.21B 256.05B 248.74B 225.98B 213.65B 200.22B 174.39B 163.22B 168.64B 164.83B 153.07B 151.58B 148.73B 157.25B 164.08B 155.74B 155.74B 155.07B
Other Current Assets
53.25B 92.07B 55.27B 94.02B 46.54B 42.73B 51.57B 51.91B 50.98B 44.8B 45B 49.28B 50.54B 45.74B 41.63B 41.23B 33.64B 35.47B 36.99B 35.66B
Total Current Assets
1,201.3B 1,203.9B 1,203B 1,240.7B 1,194.7B 1,050.1B 1,116.8B 1,317.5B 1,050B 1,072.6B 1,059.1B 989.28B 923.35B 939.33B 876.45B 868.72B 872.59B 863.29B 819.9B 795.98B
Property-Plant & Equipment
328.92B 332.72B 315.35B 309.69B 293.74B 289.03B 296.56B 290.78B 286.46B 269.11B 280.55B 280.18B 269.04B 267.82B 266.67B 269.7B 264.62B 255.18B 265.67B 267.11B
Goodwill & Intangibles
1,538.9B 1,644.1B 1,721B 1,946.8B 1,872.5B 1,840.3B 1,936.4B 946.11B 890.91B 940.61B 1,006.7B 974.09B 926.46B 945.9B 925.97B 914.44B 1,219.4B 964.96B 960.7B 1,006.3B
Total Long-Term Assets
2,138.2B 2,247.7B 2,259.2B 2,494.8B 2,374.9B 2,318.6B 2,426.3B 1,480.5B 1,406.6B 1,441.4B 1,524.5B 1,492.6B 1,409B 1,416.9B 1,385.1B 1,380.7B 1,401B 1,433.5B 1,417.1B 1,460.1B
Total Assets
3,339.5B 3,451.6B 3,462.2B 3,735.5B 3,569.6B 3,368.7B 3,543B 2,798B 2,456.5B 2,513.9B 2,583.7B 2,481.8B 2,332.4B 2,356.2B 2,261.5B 2,249.5B 2,273.6B 2,296.8B 2,237B 2,256B
Account Payables
187.84B 204.31B 161.17B 173.15B 185.19B 150.43B 147.25B 138.44B 140.24B 134.24B 146.53B 152.22B 130.74B 136.89B 111.57B 108.45B 124.78B 111B 113.51B 132.65B
Deferred Revenue
n/a n/a n/a n/a 38.52B 34.82B 31.32B 16.27B 5.14B n/a n/a n/a 32.39B n/a n/a n/a 8.39B n/a n/a n/a
Short-Term Debt
266.53B 329.85B 307.26B 549.6B 487.22B 407.18B 416.56B 309B 75B n/a n/a n/a 157.73B n/a n/a n/a 136.1B n/a n/a n/a
Other Current Liabilities
572.69B 618.4B 588.89B 651.07B 574.79B 561.29B 567.13B 527.78B 505.66B 553.22B 588.63B 569.46B 366.55B 439.1B 430.82B 458.49B 323.1B 498.25B 483.75B 502.88B
Total Current Liabilities
1,061.6B 1,152.6B 1,093.4B 1,373.8B 1,285.7B 1,153.7B 1,162.3B 991.49B 726.03B 705.9B 761.41B 740.54B 687.41B 597.98B 554.77B 581.58B 592.37B 635.85B 616.93B 647.67B
Long-Term Debt
564.89B 585.51B 620.24B 443.06B 520.69B 465.95B 475.35B 50B 50B n/a n/a n/a n/a n/a n/a n/a n/a 1.25B 2.75B 2.82B
Other Long-Term Liabilities
194.43B 219.75B 195.18B 242.2B 96.44B 146.09B 165.25B 178.05B 111.07B 93.26B 95.36B 95.5B 130.34B 91.11B 84.72B 83.95B 232.98B 291.14B 287.71B 298.86B
Total Long-Term Liabilities
764.68B 805.26B 839.04B 685.26B 687.89B 711.71B 741.42B 228.05B 222.53B 237.62B 172.73B 202.25B 184.68B 291.98B 289.12B 285.01B 295.14B 292.39B 290.45B 301.68B
Total Liabilities
1,826.3B 1,957.8B 1,932.4B 2,059.1B 1,973.6B 1,865.4B 1,903.7B 1,219.5B 948.56B 943.52B 934.14B 942.79B 872.09B 889.95B 843.89B 866.59B 887.51B 928.23B 907.39B 949.35B
Total Debt
831.43B 915.36B 927.5B 992.66B 1,005.7B 970.65B 990.43B 359B 200.01B 148.74B 82.39B 111.62B 212.74B 201.53B 204.84B 201.36B 278.26B 1.25B 2.75B 2.82B
Common Stock
103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B 103B
Retained Earnings
740.94B 654.06B 817.61B 783.78B 809.4B 838.62B 884.51B 884.53B 908.16B 996.25B 1,003.6B 924.98B 944.26B 999.64B 985.23B 945.96B 953.29B 963.01B 941.85B 918.89B
Comprehensive Income
n/a 590.22B n/a 645.6B 533.3B 412.8B 504.1B 444.72B 340.64B 313.61B 386.12B 355.4B 247.51B 200.13B 166.46B 171.91B 265.45B 132.14B 114.64B 115.03B
Shareholders Equity
1,513.3B 1,493.8B 1,529.8B 1,676.4B 1,596B 1,503.3B 1,639.3B 1,578.4B 1,508B 1,570.4B 1,649.5B 1,539.1B 1,460.3B 1,466.3B 1,417.6B 1,382.9B 1,386.1B 1,368.6B 1,329.6B 1,306.7B
Total Investments
18.99B 19.15B 123.04B 19.48B 144.42B 138.03B 140.33B 133.45B 134.75B 127.51B 128.96B 133.41B 131.68B 134.67B 128.05B 132.4B 136.89B 181.86B 143.22B 135.78B